Your shopping cart is currently empty

AAK1-IN-3 is a quinoline analogue that can be used in the research of neuropathic pain. AAK1-IN-3 is a brain-penetrant inhibitor of adaptor protein 2-associated kinase 1 (AAK1) (IC 50 = 11 nM) [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $1,980 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,500 | 8-10 weeks | 8-10 weeks |
| Description | AAK1-IN-3 is a quinoline analogue that can be used in the research of neuropathic pain. AAK1-IN-3 is a brain-penetrant inhibitor of adaptor protein 2-associated kinase 1 (AAK1) (IC 50 = 11 nM) [1]. |
| In vitro | AAK1-IN-3 (compound (R)-31) is a brain-penetrant kinase inhibitor with a blood/plasma (B/P) ratio of 1.3 [1]. It demonstrates effective inhibition of AAK1 in HEK293 cells, with an IC50 of 108 nM [1]. |
| In vivo | AAK1-IN-3 (compound (R)-31; 30 mg/kg; sc; single dose) reduces μ2 phosphorylation by 46% in C57BL6 mice [1]. |
| Molecular Weight | 316.4 |
| Formula | C20H20N4 |
| Cas No. | 1802703-20-3 |
| Smiles | C(#N)C=1C2=C(N=C([C@@H](CC(C)C)N)C1)C=CC(=C2)C=3C=CN=CC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.